Stocktoria

REGENTIS BIOMATERIALS LTD. RGNT

NYSE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies

REGENTIS BIOMATERIALS LTD. statistics & valuation

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-287.70% 20242025
Shares outstanding
2.8M 5.2M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
996.10% -179.20% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
$1.72 -$24.16 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-179.2%996.1%
Return on equity-287.7%-11.7%

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.